Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
Payne, Kyle K.
Toor, Amir A.
Manjili, Masoud H.
- Publisher: Hindawi Publishing Corporation
Clinical and Developmental Immunology,
(issn: 1740-2522, eissn: 1740-2530)
RC581-607 | Review Article | Immunologic diseases. Allergy | Article Subject
mesheuropmc: chemical and pharmacologic phenomena
The advancement of cancer immunotherapy faces barriers which limit its efficacy. These include weak immunogenicity of the tumor, as well as immunosuppressive mechanisms which prevent effective antitumor immune responses. Recent studies suggest that aberrant expression o...